Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Gross Profit (2018 - 2025)

Historic Gross Profit for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $1.8 million.

  • Dna X's Gross Profit fell 5708.88% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 2883.14%. This contributed to the annual value of $9.9 million for FY2024, which is 4866.49% down from last year.
  • Latest data reveals that Dna X reported Gross Profit of $1.8 million as of Q3 2025, which was down 5708.88% from $845000.0 recorded in Q2 2025.
  • In the past 5 years, Dna X's Gross Profit ranged from a high of $8.4 million in Q1 2025 and a low of -$487000.0 during Q4 2021
  • Its 5-year average for Gross Profit is $3.1 million, with a median of $2.9 million in 2024.
  • As far as peak fluctuations go, Dna X's Gross Profit plummeted by 11305.98% in 2021, and later soared by 90739.22% in 2022.
  • Over the past 5 years, Dna X's Gross Profit (Quarter) stood at -$487000.0 in 2021, then soared by 907.39% to $3.9 million in 2022, then skyrocketed by 30.21% to $5.1 million in 2023, then tumbled by 103.57% to -$183000.0 in 2024, then skyrocketed by 1092.35% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $845000.0 for Q2 2025, and $8.4 million during Q1 2025.